| For: | Raza S, Rajak S, Singh R, Zhou J, Sinha RA, Goel A. Cell-type specific role of autophagy in the liver and its implications in non-alcoholic fatty liver disease. World J Hepatol 2023; 15(12): 1272-1283 [PMID: 38192406 DOI: 10.4254/wjh.v15.i12.1272] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v15/i12/1272.htm |
| Number | Citing Articles |
| 1 |
Marzia Friuli, Christian Sepe, Elisabetta Panza, Cristina Travelli, Irene Paterniti, Adele Romano. Autophagy and inflammation an intricate affair in the management of obesity and metabolic disorders: evidence for novel pharmacological strategies?. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1407336
|
| 2 |
Md Entaz Bahar, Deok Ryong Kim. Cell type–specific paradox of autophagy and senescence in MASH: implications for precision hepatology. Frontiers in Cell and Developmental Biology 2026; 14 doi: 10.3389/fcell.2026.1837383
|
| 3 |
Xiangqiong Li, Kunnu Jin, Jindong Fang, Xuan Ma, Jiamei He, Ancheng Lu, Zhuangzhuang Jia, Anhua Shi. Immune crosstalk in metabolic dysfunction-associated steatotic liver disease: interactions between innate and adaptive immunity. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1835197
|
| 4 |
Sana Raza, Sangam Rajak, Paul M. Yen, Rohit A. Sinha. Autophagy and hepatic lipid metabolism: mechanistic insight and therapeutic potential for MASLD. npj Metabolic Health and Disease 2024; 2(1) doi: 10.1038/s44324-024-00022-5
|
| 5 |
Ziwei Guo, Qinjuan Wu, Pengfei Xie, Jiuchong Wang, Wenliang Lv. Immunomodulation in non-alcoholic fatty liver disease: exploring mechanisms and applications. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1336493
|
| 6 |
Sébastien Blaise, Sylviane Muller. Autoimmunity, diet and autophagy. Autoimmunity Reviews 2026; 25(5) doi: 10.1016/j.autrev.2026.104040
|
| 7 |
Roberto Palacios-Ramírez, Daniel E. Francés, Omar Motiño García-Miguel. Autophagy in age-related liver disease. Geromedicine 2025; doi: 10.70401/Geromedicine.2025.0005
|
| 8 |
Qinghui Niu, Ting Wang, Jinjin Li, Liu Zhao, Jinzhen Cai. Molecular Therapy for Non‐Alcoholic Fatty Liver Disease: Angiotensin‐(1–7) Delivery via Cyclic RGD‐Modified Vesicles Activates Mas Receptor to Ameliorate Fibrosis Through Autophagy and Metabolic Reprogramming. The FASEB Journal 2026; 40(2) doi: 10.1096/fj.202502446R
|
| 9 |
Rohit A. Sinha. Thyroid Hormone-Mediated Selective Autophagy and Its Implications in Countering Metabolic Dysfunction-Associated Steatotic Liver Disease. Endocrinology and Metabolism 2024; 39(5) doi: 10.3803/EnM.2024.2068
|
| 10 |
Ioannis Tsomidis, Angeliki Tsakou, Argyro Voumvouraki, Elias Kouroumalis. The Role of Kupffer Cells and Liver Macrophages in the Pathogenesis of Metabolic Dysfunction-Associated Steatotic Liver Disease. Biomedicines 2026; 14(1) doi: 10.3390/biomedicines14010151
|
| 11 |
Ningxi Wang, Li Song, Yue Peng, Langqiu Wei, Zhaofan Long, Che Wang, Qiling Liu, Chuandao Shi. Kangshujiangu granules improve NAFLD via cross-organ autophagy activation shared with osteoporosis. Frontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1633813
|
| 12 |
Sangam Rajak. Dynamics of cellular plasticity in non-alcoholic steatohepatitis (NASH). Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2024; 1870(4) doi: 10.1016/j.bbadis.2024.167102
|
| 13 |
Yu Hui, Qin Liu. Post-Exposure 3-Methyladenine Is Associated with Lower Indices of Hepatic Injury and Fibrotic Remodeling After Chronic Sodium Arsenite Exposure in Mice. Toxics 2026; 14(10) doi: 10.3390/toxics14100873
|
| 14 |
Wenbo Yan, Xiyuan Xu, Xiaojuan Li, Yushu Ma, Lining Guo, Jingping Yang, Zhipeng Jin, Jie Zhang, Tiewei Li. Neutrophil Extracellular Traps in Sepsis and Sepsis-Related Organ Dysfunction. ImmunoTargets and Therapy 2025; doi: 10.2147/ITT.S569962
|
| 15 |
S. A. Dmitrieva, D. M. Giniyatullina, D. S. Vologin, A. A. Ponomareva. Structural and Functional Characterization of the Mouse Liver during Intermittent Fasting. Journal of Evolutionary Biochemistry and Physiology 2026; 62(2) doi: 10.1134/S0022093026020079
|